Fractyl Announces Tenth Trial Site Opened in REVITA-T2Di Study of Revita® DMR
01 Sep 2021 //
BUSINESSWIRE
Fractyl Announces Closing of $100 Million Series F Financing
16 Jun 2021 //
BUSINESSWIRE
Fractyl Laboratories recharges with a fresh $100M and a new name
16 Jun 2021 //
ENDPTS
Fractyl Announces Closing of $100 Million Series F Financing
15 Jun 2021 //
BUSINESSWIRE
Fractyl Laboratories recharges with a fresh $100M and a new name
15 Jun 2021 //
ENDPTS
Fractyl Announces FDA Breakthrough Device Designation for Revita®
27 Apr 2021 //
BUSINESSWIRE

Market Place
Sourcing Support